Anticalcifying nanoparticle antibody titer is an independent risk factor for coronary artery calcification

TULUNAY KAYA C., ERTAŞ F. S., Hasan T., CANDEMİR B., ÖZDÖL Ç., Akan O. A., ...More

CORONARY ARTERY DISEASE, vol.22, no.6, pp.394-400, 2011 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 22 Issue: 6
  • Publication Date: 2011
  • Doi Number: 10.1097/mca.0b013e3283487d7f
  • Journal Name: CORONARY ARTERY DISEASE
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.394-400
  • Keywords: antibody, calcifying nanoparticles, coronary artery calcification, electron beam computed tomography, multidetector computed tomography, nanobacteria, HEART-DISEASE EVENTS, ELECTRON-BEAM, COMPUTED-TOMOGRAPHY, PROGNOSTIC VALUE, PSAMMOMA BODIES, CALCIUM SCORE, YOUNG-ADULTS, NANOBACTERIA, SERUM, ATHEROSCLEROSIS
  • Ankara University Affiliated: Yes

Abstract

Background Calcium phosphate deposition is present even in the early phases of the atherosclerotic plaque formation. Calcifying nanoparticles (CNPs), previously known as nanobacteria, have emerged as a potential causative agent for pathological calcification in human vasculature. This study investigates the relationship between the anti-CNPs antibody titers and the extent of coronary calcification.